 | • レポートコード：D005-12023 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ペット用医薬品の世界市場を広く調査・分析し、今後の市場展望をまとめております。ペット用医薬品の種類別市場規模（ピル、注射、スプレー、軟膏、その他）、用途別市場規模（治療、予防）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Zoetis、Virbac Group、Elanco、Merck Animal Health、Novartis、Merial、Vétoquinol S.A.、Boehringer Ingolheim、Bayer、Ceva Sante Animale ・地域別グローバル市場分析 2015年-2020年 ・ペット用医薬品の北米市場（アメリカ、カナダ、メキシコ） ・ペット用医薬品のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ペット用医薬品のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ペット用医薬品の南米市場（ブラジル、アルゼンチン） ・ペット用医薬品の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ピル、注射、スプレー、軟膏、その他 ・用途別分析：治療、予防 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Pet Pharmaceuticals market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Pet Pharmaceuticals market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Pet Pharmaceuticals market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Pet Pharmaceuticals market has been segmented into
Pill
Injection
Spray
Ointment
Others
By Application, Pet Pharmaceuticals has been segmented into:
Treatment
Prevention
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pet Pharmaceuticals market presented in the report. This section sheds light on the sales growth of different regional and country-level Pet Pharmaceuticals markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pet Pharmaceuticals market.
The report offers in-depth assessment of the growth and other aspects of the Pet Pharmaceuticals market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Pet Pharmaceuticals Market Share Analysis
Pet Pharmaceuticals competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pet Pharmaceuticals sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pet Pharmaceuticals sales, revenue and market share for each player covered in this report.
The major players covered in Pet Pharmaceuticals are:
Zoetis
Virbac Group
Elanco
Merck Animal Health
Novartis
Merial
Vétoquinol S.A.
Boehringer Ingolheim
Bayer
Ceva Sante Animale
Among other players domestic and global, Pet Pharmaceuticals market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pet Pharmaceuticals product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pet Pharmaceuticals, with price, sales, revenue and global market share of Pet Pharmaceuticals in 2018 and 2019.
Chapter 3, the Pet Pharmaceuticals competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pet Pharmaceuticals breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Pet Pharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Pet Pharmaceuticals sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Pet Pharmaceuticals Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pet Pharmaceuticals Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Pill
1.2.3 Injection
1.2.4 Spray
1.2.5 Ointment
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Pet Pharmaceuticals Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Treatment
1.3.3 Prevention
1.4 Overview of Global Pet Pharmaceuticals Market
1.4.1 Global Pet Pharmaceuticals Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Zoetis
2.1.1 Zoetis Details
2.1.2 Zoetis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Zoetis SWOT Analysis
2.1.4 Zoetis Product and Services
2.1.5 Zoetis Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Virbac Group
2.2.1 Virbac Group Details
2.2.2 Virbac Group Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Virbac Group SWOT Analysis
2.2.4 Virbac Group Product and Services
2.2.5 Virbac Group Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Elanco
2.3.1 Elanco Details
2.3.2 Elanco Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Elanco SWOT Analysis
2.3.4 Elanco Product and Services
2.3.5 Elanco Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck Animal Health
2.4.1 Merck Animal Health Details
2.4.2 Merck Animal Health Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck Animal Health SWOT Analysis
2.4.4 Merck Animal Health Product and Services
2.4.5 Merck Animal Health Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novartis SWOT Analysis
2.5.4 Novartis Product and Services
2.5.5 Novartis Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merial
2.6.1 Merial Details
2.6.2 Merial Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merial SWOT Analysis
2.6.4 Merial Product and Services
2.6.5 Merial Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Vétoquinol S.A.
2.7.1 Vétoquinol S.A. Details
2.7.2 Vétoquinol S.A. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Vétoquinol S.A. SWOT Analysis
2.7.4 Vétoquinol S.A. Product and Services
2.7.5 Vétoquinol S.A. Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Boehringer Ingolheim
2.8.1 Boehringer Ingolheim Details
2.8.2 Boehringer Ingolheim Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Boehringer Ingolheim SWOT Analysis
2.8.4 Boehringer Ingolheim Product and Services
2.8.5 Boehringer Ingolheim Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bayer
2.9.1 Bayer Details
2.9.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bayer SWOT Analysis
2.9.4 Bayer Product and Services
2.9.5 Bayer Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Ceva Sante Animale
2.10.1 Ceva Sante Animale Details
2.10.2 Ceva Sante Animale Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Ceva Sante Animale SWOT Analysis
2.10.4 Ceva Sante Animale Product and Services
2.10.5 Ceva Sante Animale Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Pet Pharmaceuticals Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Pet Pharmaceuticals Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Pet Pharmaceuticals Manufacturer Market Share in 2019
3.3.2 Top 6 Pet Pharmaceuticals Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Pet Pharmaceuticals Sales, Revenue and Market Share by Regions
4.1.1 Global Pet Pharmaceuticals Sales and Market Share by Regions (2015-2020)
4.1.2 Global Pet Pharmaceuticals Revenue and Market Share by Regions (2015-2020)
4.2 North America Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
4.3 Europe Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
4.5 South America Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Pet Pharmaceuticals Sales, Revenue and Market Share by Country
5.1.1 North America Pet Pharmaceuticals Sales and Market Share by Country (2015-2020)
5.1.2 North America Pet Pharmaceuticals Revenue and Market Share by Country (2015-2020)
5.2 United States Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
5.3 Canada Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
5.4 Mexico Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Pet Pharmaceuticals Sales, Revenue and Market Share by Country
6.1.1 Europe Pet Pharmaceuticals Sales and Market Share by Country (2015-2020)
6.1.2 Europe Pet Pharmaceuticals Revenue and Market Share by Country (2015-2020)
6.2 Germany Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
6.3 UK Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
6.4 France Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
6.5 Russia Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
6.6 Italy Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Pet Pharmaceuticals Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Pet Pharmaceuticals Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Pet Pharmaceuticals Revenue and Market Share by Regions (2015-2020)
7.2 China Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
7.3 Japan Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
7.4 Korea Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
7.5 India Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
7.7 Australia Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Pet Pharmaceuticals Sales, Revenue and Market Share by Country
8.1.1 South America Pet Pharmaceuticals Sales and Market Share by Country (2015-2020)
8.1.2 South America Pet Pharmaceuticals Revenue and Market Share by Country (2015-2020)
8.2 Brazil Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
8.3 Argentina Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Pet Pharmaceuticals Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Pet Pharmaceuticals Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Pet Pharmaceuticals Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
9.3 Turkey Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
9.4 Egypt Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
9.5 South Africa Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Pet Pharmaceuticals Sales and Market Share by Type (2015-2020)
10.2 Global Pet Pharmaceuticals Revenue and Market Share by Type (2015-2020)
10.3 Global Pet Pharmaceuticals Price by Type (2015-2020)
11 Global Pet Pharmaceuticals Market Segment by Application
11.1 Global Pet Pharmaceuticals Sales Market Share by Application (2015-2020)
11.2 Global Pet Pharmaceuticals Revenue Market Share by Application (2015-2020)
11.3 Global Pet Pharmaceuticals Price by Application (2015-2020)
12 Market Forecast
12.1 Global Pet Pharmaceuticals Sales, Revenue and Growth Rate (2021-2025)
12.2 Pet Pharmaceuticals Market Forecast by Regions (2021-2025)
12.2.1 North America Pet Pharmaceuticals Market Forecast (2021-2025)
12.2.2 Europe Pet Pharmaceuticals Market Forecast (2021-2025)
12.2.3 Asia-Pacific Pet Pharmaceuticals Market Forecast (2021-2025)
12.2.4 South America Pet Pharmaceuticals Market Forecast (2021-2025)
12.2.5 Middle East & Africa Pet Pharmaceuticals Market Forecast (2021-2025)
12.3 Pet Pharmaceuticals Market Forecast by Type (2021-2025)
12.3.1 Global Pet Pharmaceuticals Sales Forecast by Type (2021-2025)
12.3.2 Global Pet Pharmaceuticals Market Share Forecast by Type (2021-2025)
12.4 Pet Pharmaceuticals Market Forecast by Application (2021-2025)
12.4.1 Global Pet Pharmaceuticals Sales Forecast by Application (2021-2025)
12.4.2 Global Pet Pharmaceuticals Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Pet Pharmaceuticals Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pet Pharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pet Pharmaceuticals Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Zoetis Basic Information, Manufacturing Base and Competitors
Table 8. Zoetis Pet Pharmaceuticals Major Business
Table 9. Zoetis Pet Pharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 10. Zoetis SWOT Analysis
Table 11. Zoetis Pet Pharmaceuticals Product and Services
Table 12. Zoetis Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Virbac Group Basic Information, Manufacturing Base and Competitors
Table 14. Virbac Group Pet Pharmaceuticals Major Business
Table 15. Virbac Group Pet Pharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 16. Virbac Group SWOT Analysis
Table 17. Virbac Group Pet Pharmaceuticals Product and Services
Table 18. Virbac Group Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Elanco Basic Information, Manufacturing Base and Competitors
Table 20. Elanco Pet Pharmaceuticals Major Business
Table 21. Elanco Pet Pharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 22. Elanco SWOT Analysis
Table 23. Elanco Pet Pharmaceuticals Product and Services
Table 24. Elanco Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 26. Merck Animal Health Pet Pharmaceuticals Major Business
Table 27. Merck Animal Health Pet Pharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 28. Merck Animal Health SWOT Analysis
Table 29. Merck Animal Health Pet Pharmaceuticals Product and Services
Table 30. Merck Animal Health Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Novartis Basic Information, Manufacturing Base and Competitors
Table 32. Novartis Pet Pharmaceuticals Major Business
Table 33. Novartis Pet Pharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 34. Novartis SWOT Analysis
Table 35. Novartis Pet Pharmaceuticals Product and Services
Table 36. Novartis Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Merial Basic Information, Manufacturing Base and Competitors
Table 38. Merial Pet Pharmaceuticals Major Business
Table 39. Merial Pet Pharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 40. Merial SWOT Analysis
Table 41. Merial Pet Pharmaceuticals Product and Services
Table 42. Merial Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Vétoquinol S.A. Basic Information, Manufacturing Base and Competitors
Table 44. Vétoquinol S.A. Pet Pharmaceuticals Major Business
Table 45. Vétoquinol S.A. Pet Pharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 46. Vétoquinol S.A. SWOT Analysis
Table 47. Vétoquinol S.A. Pet Pharmaceuticals Product and Services
Table 48. Vétoquinol S.A. Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Boehringer Ingolheim Basic Information, Manufacturing Base and Competitors
Table 50. Boehringer Ingolheim Pet Pharmaceuticals Major Business
Table 51. Boehringer Ingolheim Pet Pharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 52. Boehringer Ingolheim SWOT Analysis
Table 53. Boehringer Ingolheim Pet Pharmaceuticals Product and Services
Table 54. Boehringer Ingolheim Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Bayer Basic Information, Manufacturing Base and Competitors
Table 56. Bayer Pet Pharmaceuticals Major Business
Table 57. Bayer Pet Pharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 58. Bayer SWOT Analysis
Table 59. Bayer Pet Pharmaceuticals Product and Services
Table 60. Bayer Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Ceva Sante Animale Basic Information, Manufacturing Base and Competitors
Table 62. Ceva Sante Animale Pet Pharmaceuticals Major Business
Table 63. Ceva Sante Animale Pet Pharmaceuticals Total Revenue (USD Million) (2017-2018)
Table 64. Ceva Sante Animale SWOT Analysis
Table 65. Ceva Sante Animale Pet Pharmaceuticals Product and Services
Table 66. Ceva Sante Animale Pet Pharmaceuticals Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Pet Pharmaceuticals Sales by Manufacturer (2018-2019) (K MT)
Table 68. Global Pet Pharmaceuticals Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Pet Pharmaceuticals Sales by Regions (2015-2020) (K MT)
Table 70. Global Pet Pharmaceuticals Sales Market Share by Regions (2015-2020)
Table 71. Global Pet Pharmaceuticals Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Pet Pharmaceuticals Sales by Countries (2015-2020) (K MT)
Table 73. North America Pet Pharmaceuticals Sales Market Share by Countries (2015-2020)
Table 74. North America Pet Pharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Pet Pharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 76. Europe Pet Pharmaceuticals Sales by Countries (2015-2020) (K MT)
Table 77. Europe Pet Pharmaceuticals Sales Market Share by Countries (2015-2020)
Table 78. Europe Pet Pharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Pet Pharmaceuticals Sales by Regions (2015-2020) (K MT)
Table 80. Asia-Pacific Pet Pharmaceuticals Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Pet Pharmaceuticals Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Pet Pharmaceuticals Sales by Countries (2015-2020) (K MT)
Table 83. South America Pet Pharmaceuticals Sales Market Share by Countries (2015-2020)
Table 84. South America Pet Pharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Pet Pharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Pet Pharmaceuticals Sales by Countries (2015-2020) (K MT)
Table 87. Middle East & Africa Pet Pharmaceuticals Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Pet Pharmaceuticals Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Pet Pharmaceuticals Revenue Market Share by Countries (2015-2020)
Table 90. Global Pet Pharmaceuticals Sales by Type (2015-2020) (K MT)
Table 91. Global Pet Pharmaceuticals Sales Share by Type (2015-2020)
Table 92. Global Pet Pharmaceuticals Revenue by Type (2015-2020) (USD Million)
Table 93. Global Pet Pharmaceuticals Revenue Share by Type (2015-2020)
Table 94. Global Pet Pharmaceuticals Sales by Application (2015-2020) (K MT)
Table 95. Global Pet Pharmaceuticals Sales Share by Application (2015-2020)
Table 96. Global Pet Pharmaceuticals Sales Forecast by Regions (2021-2025) (K MT)
Table 97. Global Pet Pharmaceuticals Market Share Forecast by Regions (2021-2025)
Table 98. Global Pet Pharmaceuticals Sales Forecast by Type (2021-2025) (K MT)
Table 99. Global Pet Pharmaceuticals Market Share Forecast by Type (2021-2025)
Table 100. Global Pet Pharmaceuticals Sales Forecast by Application (2021-2025)
Table 101. Global Pet Pharmaceuticals Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Pet Pharmaceuticals Picture
Figure 2. Global Sales Market Share of Pet Pharmaceuticals by Type in 2019
Figure 3. Pill Picture
Figure 4. Injection Picture
Figure 5. Spray Picture
Figure 6. Ointment Picture
Figure 7. Others Picture
Figure 8. Pet Pharmaceuticals Sales Market Share by Application in 2018
Figure 9. Treatment Picture
Figure 10. Prevention Picture
Figure 11. Global Pet Pharmaceuticals Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Pet Pharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Pet Pharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Pet Pharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Pet Pharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Pet Pharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Pet Pharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Pet Pharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Pet Pharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Pet Pharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Pet Pharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Pet Pharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Pet Pharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Pet Pharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Pet Pharmaceuticals Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Pet Pharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Pet Pharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Pet Pharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Pet Pharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Pet Pharmaceuticals Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Pet Pharmaceuticals Sales Market Share by Manufacturer in 2019
Figure 32. Global Pet Pharmaceuticals Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Pet Pharmaceuticals Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Pet Pharmaceuticals Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Pet Pharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 37. Global Pet Pharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Pet Pharmaceuticals Revenue Market Share by Regions (2015-2020)
Figure 39. Global Pet Pharmaceuticals Revenue Market Share by Regions in 2018
Figure 40. North America Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
Figure 41. Europe Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
Figure 43. South America Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Pet Pharmaceuticals Sales and Growth Rate (2015-2020)
Figure 45. North America Pet Pharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Pet Pharmaceuticals Sales Market Share by Countries (2015-2020)
Figure 47. North America Pet Pharmaceuticals Sales Market Share by Countries in 2018
Figure 48. North America Pet Pharmaceuticals Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Pet Pharmaceuticals Revenue Market Share by Countries in 2018
Figure 50. United States Pet Pharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 51. Canada Pet Pharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 52. Mexico Pet Pharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Europe Pet Pharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Pet Pharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Pet Pharmaceuticals Revenue Market Share by Countries in 2019
Figure 56. Germany Pet Pharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 57. UK Pet Pharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 58. France Pet Pharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 59. Russia Pet Pharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 60. Italy Pet Pharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Asia-Pacific Pet Pharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Pet Pharmaceuticals Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Pet Pharmaceuticals Revenue Market Share by Regions 2019
Figure 64. China Pet Pharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Japan Pet Pharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 66. Korea Pet Pharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 67. India Pet Pharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 68. Southeast Asia Pet Pharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 69. South America Pet Pharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Pet Pharmaceuticals Sales Market Share by Countries in 2019
Figure 71. South America Pet Pharmaceuticals Revenue Market Share by Countries in 2019
Figure 72. Brazil Pet Pharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 73. Argentina Pet Pharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 74. Middle East and Africa Pet Pharmaceuticals Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Pet Pharmaceuticals Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Pet Pharmaceuticals Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Pet Pharmaceuticals Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Pet Pharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Egypt Pet Pharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 80. Turkey Pet Pharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 81. South Africa Pet Pharmaceuticals Sales and Growth Rate (2015-2020) (K MT)
Figure 82. Global Pet Pharmaceuticals Sales and Growth Rate (2021-2025) (K MT)
Figure 83. Global Pet Pharmaceuticals Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Pet Pharmaceuticals Market Forecast (2021-2025) (K MT)
Figure 85. Europe Sales Pet Pharmaceuticals Market Forecast (2021-2025) (K MT)
Figure 86. Asia-Pacific Sales Pet Pharmaceuticals Market Forecast (2021-2025) (K MT)
Figure 87. South America Sales Pet Pharmaceuticals Market Forecast (2021-2025) (K MT)
Figure 88. Middle East & Africa Sales Pet Pharmaceuticals Market Forecast (2021-2025) (K MT)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
局所抗生物質医薬品の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Topical Antibiotic Pharmaceuticals market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Topical An…- 複合クロトリマゾール軟膏の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Compound Clotrimazole Ointment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Compound Clotr…
- 医療用医薬品の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Ethical Pharmaceuticals market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Ethical Pharmaceutica…
- 医薬品包装の世界市場 2020年：メーカー別、地域別、種類・用途別 Summary Market Overview The global Pharmaceuticals Packaging market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Pharmaceuti…
- 腫瘍用注射薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Oncology Injection Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oncology Injection Dr…